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Summary We have examined the incidence of non-AIDS-related Kaposi's sarcoma in Iceland (1955-79) and the Faroe Islands (1974-95).
In Iceland, 19 cases, nine in men and ten in women, were identified, and in the Faroe Islands four cases in men and three cases in women
were found. This corresponded to surprisingly high incidence rates. In men, world standardized rates (per 100 000 person-years) were 0.4
and 0.6 in Iceland and the Faroe Islands, respectively, and for women, the figures were 0.3 (Iceland) and 0.5 (the Faroe Islands). These are
among the highest rates ever reported. No explanation for the high rates of Kaposi's sarcoma in these two North Atlantic communities could
be identified.
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From an increasing number of epidemiological studies it has
become evident that the incidence of classical Kaposi's sarcoma
(KS) differs considerably between Caucasian populations. Accord-
ingly, within Europe alone, reported annual rates per 100 000
persons have varied from 2.43 and 0.77 in Sardinian men and
women, respectively, in the period 1977-91, to 0.014 in both men
and women in the UK in the period 1971-80 (Grulich et al, 1992;
Cottoni et al, 1996).
The pronounced geographical gradient in incidence ofclassical
KS in Europe, with high rates observed in the Mediterranean area
and low rates in northern areas, is in accordance with other studies
suggesting a disproportionately high number of persons of south-
European descent among patients with classical KS even in non-
Mediterranean countries (DiGiovanna and Safai, 1981; Grulich et
al, 1992; Kaldor et al, 1994; Hjalgrim et al, 1996a). However, in a
recent study of classical KS in four Nordic countries (Sweden,
Norway, Finland and Denmark) before the AIDS epidemic, we
reported that highly significant variation in incidence amounting
to eightfold in women and 13-fold in men may also exist between
four ethnically very similar, neighbouring populations (Hjalgrim
et al, 1996b). As this variation could not be attributed to any
known risk factor for classical KS, including proportion of
immigrants from high-risk areas, transplantations, diagnostic or
registrational procedures, it may suggest the existence of an envi-
ronmental factor of significance for the development of KS
(Hjalgrim et al, 1996b).
Intrigued by the variation in KS incidence between these four
countries, we ascertained the incidence of classical KS in two
other geographically distinct Nordic populations, Iceland and the
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Faroe Islands, populated by approximately 220 000 and 45 000
persons, respectively, in 1980.
MATERIAL AND METHODS
Case-ascertainment procedures
The Icelandic Cancer Registry has registered KS separately since
its establishment in 1955. For the purpose ofthe present study, all
reports of KS in the registry in the period until 1979 were identi-
fied, and the original histological specimens were reviewed by one
of us (SH) to confirm the diagnosis. The limitation of the study
period was applied to avoid misclassification of cases of AIDS-
related KS, because AIDS diagnoses are not recorded by the
registry. Although attempts have been made to initiate continuous
cancer surveillance on the Faroe Islands previously, reporting and
registration of cancers has only recently become mandatory. To
obtain as complete retrospective information as possible for the
Faroese registry, scrutiny ofpathology reports, hospital discharge
records and death certificates is part of the case-ascertainment
procedure. Within the files of the current registry, all cases of KS
diagnosed on the Faroe Islands between 1974 and 1995 were iden-
tifiedforthe purpose ofthe present study. Because ofthe extensive
validation procedure for all cancers in the registry, cases ofAIDS-
related KS couldreadily be identified andexcludedfromthe study.
As in Iceland, all original histological specimens were reviewed to
confirm the diagnosis.
Statistical procedures
Forboth countries, age adjusted incidence rates were calculated by
means ofdirect standardization, using the population ofIceland in
1970 and the Faroese population of 1983, as well as the world
standard population (Breslow and Day, 1987) as references. In
Iceland, standardized rates were calculated in 5-year periods
(1955-59, 1960-64, ..., 1975-79), whereas rates for the Faroese
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Table 1 Number of cases and incidence of KS by country, period, and sex
Incidence rates - mena Incidence rates - womena
Number World standard Local populationb Number World standard Local populationb
of cases of cases
Iceland
1955-59 0 0 0 0 0 0
1960-64 0 0 0 1 0.1 0.1
1965-69 2 0.7 0.6 3 0.3 0.5
1970-74 3 0.5 0.6 3 0.3 0.4
1975-79 4 0.6 0.7 3 0.6 0.7
9 0.4 0.4 10 0.3 0.4
The Faroe Islands
1974-84 2 0.7 0.8 2 0.7 0.9
1985-95 2 0.5 0.8 1 0.3 0.4
1974-95 4 0.6 0.8 3 0.5 0.6
aCases per 100 000 person-years; bstandardized to the Icelandic population of 1970 and the Faroese population of 1983 respectively.
population were calculated for two periods (1974-84, 1985-95)
because of the small number ofcases.
RESULTS
Overall, 19 cases of KS, nine in men and ten in women, were iden-
tified in the Icelandic Cancer Registry in the period between 1955
and 1979 (Table 1). This corresponded to overall incidence rates of
0.4 and 0.3 per 100 000 person-years (world standardized) in men
and women respectively. The median age at diagnosis of KS was
70 years (range 61-92 years) in men and 81 years (range 51-92
years) in women. At the time of diagnosis of KS, five of the
Icelandic patients, three men and two women, had never been
married. By March 1997, 17 of the patients had died, between 11
months and 14.5 years, after KS. In the Faroese Cancer Registry,
seven cases of KS, four in men and three in women, were identi-
fied between 1974 and 1995 (Table 1). This yielded overall world
standardized incidence rates of 0.6 and 0.5 (per 100 000
person-years) in men and women respectively (Table 1). In men,
the ages at diagnosis of KS were 41 years, 74 years, 81 years and
93 years, and in women 58 years, 69 years and 71 years. All
Faroese patients were married at the time of diagnosis of KS and
by the end of 1996 four of the patients had died, between 1 and 22
months after KS.
In neither population did the rates differ significantly between
men and women. None of the 26 patients were immigrants to the
two communities.
DISCUSSION
Surprisingly high incidence rates of classical KS were observed
both in Iceland and in the Faroe Islands. Thus, in both men and
women, the rates are among the highest ever reported in Caucasian
populations (Figure 1). Accordingly, among women a higher rate
has been reported only from Sardinia in the period 1977-91, aver-
aging 0.77 per 100 000 person-years (standardized to the Sardinian
population) (Cottoni et al, 1996). Adjusting the rates reported for
Sardinia (Cottoni et al, 1996) to the world standard population
(Breslow and Day, 1987), the incidence of classical KS among
women was lower in Sardinia than in both Icelandic and Faroese
women (Figure 1). Among men the observed rates are second only
to those observed in the Mediterranean area (Figure 1).
In a Nordic context, the world standardized rates in both Iceland
and the Faroe Islands by far exceeded the rates reported for
Denmark, Norway, Sweden and Finland in the period 1973-77. In
these countries world standardized rates varied from 0.01 to 0.09
per 100 000 person-years in women and from 0.02 to 0.26 per 100
000 person-years in men (Figure 1) (Hjalgrim et al, 1996b).
The remarkably high rates reported here are based on a rela-
tively small number of cases, wherefore only limited conclusions
can be drawn. However, we feel confident that the material
presented is of high quality. Accordingly, all diagnoses were
confirmed by review of original tissue specimens. Furthermore,
restriction of the study period in Iceland and review of all hospital
records in the Faroe Islands prevented inclusion of AIDS-related
KS in the study material. Finally, the rates were high in both coun-
tries for both men and women, suggesting that the present obser-
vations are not chance findings.
The high proportion of married patients in both countries does
not suggest that the high rates are caused by a disproportionate
number ofhomosexual men among the patients. Similarly, none of
the 26 patients were immigrants to the two populations. As there is
no reason to believe that the Icelandic and Faroese populations
should differ from the populations in the other Nordic countries
with respect to immunosuppressive conditions or other risk factors
for classical KS, we can provide no immediate explanation for the
high incidence of KS in these two north-Atlantic populations.
Evidence is accumulating that the newly described human
herpesvirus-8 (Chang et al, 1994) is causally linked with KS.
Thus, the virus has been found in all types of KS, and infection
with the virus seems to precede development of the disease
(Chang et al, 1994; Moore and Chang, 1995; Whitby et al, 1995).
In addition, recent serological studies have indicated that KS inci-
dence correlates with the seroprevalence of human herpesvirus-8
(Gao et al, 1996; Simpson et al, 1996). It is likely, therefore, that
the observed high rates of classical KS in Iceland and in the Faroe
Islands compared with the rest of the Nordic countries and other
Caucasian populations might correlate with geographical differ-
ences in the prevalence ofhuman herpesvirus-8.
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Figure 1 Reported incidence rates of classical KS by calendar period and country.
- - -, indicates world standardized incidence rates and indicates- rates
standardized to local populations. Sources of data: Finland, Sweden, Norway (Hjalgrim et al, 1996b), Denmark (Hjalgrim et al, 1996a), England (Grulich et al,
1992), US (Biggar et al, 1984), Australia (Kaldor et al, 1994), Italy (Geddes et al, 1994), Greece (Touloumi et al, 1997). For Sardinia, world standardized rates
have been calculated on the basis of published data (Cottoni et al, 1996). Note that in Iceland no cases of KS were observed in the period 1955-64 for men and
in the period 1955-59 for women, and that similary no cases were observed in Finnish women in the period 1958-62. *, Iceland (1959-79); O, Faroe Islands
(1974-95); +, Sardinia (1977-91), x Greece (1974-89); O, Italy (1976-84); V, Sweden (1955-79); 0, Norway (1953-79); V, USA (1973-79); *, Finland
(1953-79); 0, Australia (1972-82); A, Denmark (1970-92); A England (1971-80)
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